Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on October 12, 2021. The filing serves to distribute a press release dated October 12, 2021, to U.S. investors pursuant to Rule 13a-16 under the Securities Exchange Act of 1934.
Financial Metrics
The provided filing text contains only the cover page and exhibit index. It does not include the full text of the press release or any financial statements. Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not available in this document.
Material Changes
The filing text does not provide details regarding material changes versus prior periods. The content of the referenced press release (Exhibit 99.1) is not included in the input data.
Guidance, Outlook, and Risks
Management commentary, future guidance, risk factors, and contingencies are not disclosed in the provided text. The filing solely references the existence of a press release without summarizing its contents.
Key Facts for Investor Verification
- The filing is a procedural Form 6-K referencing a press release (Exhibit 99.1) rather than a financial report.
- Specific financial results and operational updates are absent from the provided text.
- Investors must locate and review the full text of the press release dated October 12, 2021, to obtain material information.
- The report was signed by André Choulika, Chief Executive Officer.